[1]
Sumaya B. Abdulrahman et al. 2023. Assessing the reliability of serum macrophage migration inhibitory factor as a marker for diabetic nephropathy prediction in type 2 diabetes patients and the effect of ACE inhibitors on its level. Iraqi Journal of Pharmaceutical Sciences. 32, 2 (Sep. 2023), 83–90. DOI:https://doi.org/10.31351/vol32iss2pp83-90.